Organization
University of Nottingham
3 clinical trials
6 abstracts
Abstract
Effect of intrinsic STING of CD8+T cells on self-metabolic reprogramming and anti-tumor effects.Org: Nanjing University of Traditional Chinese Medicine, University of Nottingham,
Clinical trial
Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle.Status: Recruiting, Estimated PCD: 2024-05-01
Abstract
Validation of a novel and rapid reagent free assay to predict outcomes for adjuvant therapy decision making in hormone receptor-positive breast cancer.Org: Imperial College, Imperial College London, Nottingham University Hospitals Trust, Rush University Medical College, Barts Cancer Institute,
Abstract
Long-term prospective data on correlation between overall mortality and HADS (Hospital Anxiety and Depression Scale) assessed psychological distress in prostate cancer patients (11 year follow-up data).Org: Nottingham University Hospitals NHS Trust, St Bartholomew's Hospital, Nottingham University Hospital NHS Trust, Royal United Hospitals Bath NHS Foundation Trust, University of Nottingham,
Abstract
Baseline endogenous serum testosterone levels and all-cause mortality in men with prostate cancer treated by radical radiotherapy: 11-year follow-up data.Org: Nottingham University Hospitals NHS Trust, St Bartholomew's Hospital, Nottingham University Hospital NHS Trust, Royal United Hospitals Bath NHS Foundation Trust, University of Nottingham,
Abstract
AN ANALYSIS OF PRESCRIPTION RECORDS OF GOUT PATIENTS IN EUROPE: EVIDENCE OF SUBOPTIMAL MANAGEMENT AND CLINICAL INERTIAOrg: AP-HP (hôpital Lariboisère), Inserm U567, University Paris Diderot, University of Paris-Saclay, Rheumatology Department, Gregorio Marañon General University Hospital, Madrid, Spain,
Abstract
A PAN-EUROPEAN STUDY OF MUSCULOSKELETAL PAIN: IMPACT ON QUALITY OF LIFE AND BURDEN OF DISEASEOrg: Rheumatology, Royal Cornwall Hospitals Trust, Truro, Academic Rheumatology, University of Bristol, University of Nottingham,
Clinical trial
A Phase IV, Crossover, Randomized, Double Blind and Placebo-controlled Clinical Trial to Evaluate the Mode of Action of Multiple Doses of Bisacodyl in Subjects With Occasional ConstipationStatus: Completed, Estimated PCD: 2022-11-01
Clinical trial
A Phase IV, Crossover, Randomized, Double Blind and Placebo-controlled Clinical Trial to Evaluate the Mode of Action of a Single Dose of Bisacodyl in Subjects With Occasional ConstipationStatus: Completed, Estimated PCD: 2022-11-01